The short version
Remedy Meds is a flat-rate telehealth provider. As of the August 25, 2026 build, for tirzepatide its lowest 12-month all-in total is $4,668 (month-to-month plan, verified), which places it 27 of 30 ranked telehealth providers; for semaglutide its lowest 12-month all-in total is $3,468 (month-to-month plan, verified), which places it 12 of 13 ranked telehealth providers. Verification status: verified.
The numbers, plan by plan
- Semaglutide (standard, injection, month-to-month plan): $299 per month after an introductory $179 per month for the first 1 month. Status: verified, checked August 25, 2026. $179 for the first month, then $299 per month; dose changes do not change the rate.
- Tirzepatide (standard, injection, month-to-month plan): $399 per month after an introductory $279 per month for the first 1 month. Status: verified, checked August 25, 2026. $279 for the first month, then $399 per month; dose changes do not change the rate.
Fees and what the price includes
The published price includes the medication and clinical care and shipping, with no separate membership fee. Shipping is included. The clinician consultation is included. The price does not change with dose.
How this pricing structure plays out over a year
The first 1 month costs $279 all-in; from month 2 the recurring cost is $399 a month, so the advertised $279 covers 6% of the first year's spend and the recurring price covers the rest. The price does not move with dose, which removes the largest hidden cost in this market; a patient at 15 mg pays what a patient at 2.5 mg pays.
Compared with the field
On tirzepatide, Remedy Meds's lowest twelve-month total of $4,668 is $3,168 above the lowest (Trimi, $1,500) and above the median of $3,090 across 30 ranked providers, placing it 27 of 30. On the value score it scores 59 against 92 for NexLife, the best-scoring provider; the gap comes from cost, transparency, care. On semaglutide, Remedy Meds's lowest twelve-month total of $3,468 is $2,412 above the lowest (Sunlight, $1,056) and above the median of $2,100 across 13 ranked providers, placing it 12 of 13. On the value score it scores 59 against 92 for NexLife, the best-scoring provider; the gap comes from cost, transparency, care.
Pharmacy, coverage and cancellation
The provider reports serving all fifty states. Dispensing: 503A (provider-stated; pharmacy not named). Commitment: month-to-month; prepay discounts offered. Cancellation: Cancel anytime.
Questions to ask Remedy Meds before paying
Ask, in writing: Which pharmacy fills the prescription, is it 503A or 503B, and can I see a certificate of analysis for my batch? What is the price from month two, and does it change at renewal? Will my dosing instructions state the concentration of the vial you actually ship, and will you reissue them if it changes? A provider that answers all of these promptly is operating in the open; one that will not name its pharmacy has answered the most important question.
What works
Heavily advertised introductory pricing. All-in plans without a separate membership.
What to weigh against it
Introductory prices typically step up after the first month; the recurring rate is what we rank. Pharmacy and coverage pending verification.
Who should choose Remedy Meds
Patients who want a low first-month price and are prepared for a higher recurring rate. A patient with insurance coverage for Zepbound or Wegovy should compare the copay route first; a patient who wants a verified flat all-in price with month-to-month flexibility should compare the best overall provider on our value score; and any patient should ask which pharmacy fills the prescription before paying.
How we verified this
Remedy's product pages publish semaglutide at $179 the first month then $299, and tirzepatide at $279 then $399, flat across doses; its terms state availability in all 50 states and DC and that a licensed 503A pharmacy is used (not named). Verified against the provider's own pages on 2026-08-25 (first-party verification pass).